{
    "2021-10-28": [
        [
            {
                "time": "",
                "original_text": "金域医学购买办公楼事项正在继续对接中",
                "features": {
                    "keywords": [
                        "金域医学",
                        "购买",
                        "办公楼"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "金域医学2021年三季报点评：业绩符合我们预期，常规业务保持高速推进【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "金域医学",
                        "三季报",
                        "业绩",
                        "预期",
                        "常规业务",
                        "高速推进"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东吴证券给予金域医学买入评级：业绩符合我们预期，常规业务保持高速推进",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "金域医学",
                        "买入评级",
                        "业绩",
                        "预期",
                        "常规业务",
                        "高速推进"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "206股获券商买入评级，新安股份目标涨幅达96.48%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "新安股份",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "其他"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}